AQP4 and COVID-19: The mean time from COVID-19 to ON onset was shorter in patients with MOG-ON compared to patients with AQP4-ON (6.87 ± 6.25 weeks vs. 11.06 ± 5.84 weeks; p = 0.038), indicating a closer temporal association between MOG-ON onset and COVID-19.